SCHEMBL29316802

SCHEMBL29316802

CC1CCN(C2CCC(C3CCNCC3)CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
POLB P06746 2/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALDH1A1 P00352 3/20 0.38
ALOX15 P16050 1/20 0.37
DHCR7 Q9UBM7 3/20 0.36
EBP Q15125 2/20 0.36
GNAI3 P08754 5/20 0.35
GNAO1 P09471 5/20 0.35
GNAI1 P63096 5/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.34
CYP2D6 P10635 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL310092 0.87 KDM4E (0.41) KDM4EPOLBL3MBTL3L3MBTL1ALDH1A1
SCHEMBL14628353 0.85 KDM4E (0.43) KDM4EPOLBL3MBTL3L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL310595 0.85 KDM4E (0.40) KDM4EPOLBL3MBTL3L3MBTL1ALDH1A1
SCHEMBL4475326 0.85 L3MBTL3 (0.49) L3MBTL3L3MBTL1GNAI3GNAO1GNAI1
SCHEMBL21931367 0.85 KDM4E (0.47) KDM4EPOLBALDH1A1ALOX15DHCR7
Hydrochloric Acid SCHEMBL28757439 0.83 L3MBTL3 (0.47) L3MBTL3L3MBTL1GNAI3GNAO1GNAI1
SCHEMBL30359096 0.80 KDM4E (0.40) KDM4EPOLBL3MBTL3L3MBTL1ALDH1A1
SCHEMBL22595374 0.80 HTR6 (0.38) KDM4EPOLBL3MBTL3L3MBTL1ALDH1A1
SCHEMBL26118274 0.80 KDM4E (0.47) KDM4EPOLBALDH1A1ALOX15DHCR7
SCHEMBL82615 0.80 KDM4E (0.47) KDM4EPOLBALDH1A1ALOX15DHCR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed